Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05775718 · ClinicalTrials.gov registry record · Phase 2
Shingrix In Recipients of Allogeneic Transplants
A Phase 2 study of Stem Cell Transplant and Bone Marrow Transplant, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT05775718 is a Phase 2 study of Stem Cell Transplant and Bone Marrow Transplant that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 55 participants, below the 190-participant average among 9 other Stem Cell Transplant trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05775718, a Phase 2 study of Stem Cell Transplant and Bone Marrow Transplant, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is designed to determine if the adjuvanted recombinant glycoprotein E (gE) herpes zoster (HZ) vaccine (Shingrix) has acceptable immunogenicity and safety in people who have undergone allogeneic stem cell transplant (allo-SCT). Specifically, it will determine the effect of the interval after transplantation on the immune response and if an additional dose of vaccine is needed to improve the vaccine-induced responses.
Conditions Studied
Interventions
- DRUG Zoster Vaccine Recombinant
Study Locations (1)
Colorado
- University of Colorado Hospital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2023-10-24 |
| Est. Completion | 2030-12-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05775718
The ClinicalTrials.gov registry entry for NCT05775718 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 9 other Stem Cell Transplant trials with a reported enrollment target (71% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stem Cell Transplant appearing as the primary indexed condition, and to 1 intervention - of which Zoster Vaccine Recombinant is the first listed.
NCT05775718 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05775718 about?
NCT05775718 is a clinical study titled "Shingrix In Recipients of Allogeneic Transplants". This research is designed to determine if the adjuvanted recombinant glycoprotein E (gE) herpes zoster (HZ) vaccine (Shingrix) has acceptable immunogenicity and safety in people who have undergone allogeneic stem cell transplant (allo-SCT). Specifically, it will determine the effect of the interval ...
What is the current status of trial NCT05775718?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2023-10-24. Estimated completion is 2030-12-01.
What conditions does trial NCT05775718 study?
This clinical trial studies the following conditions: Stem Cell Transplant, Bone Marrow Transplant.
What interventions are being tested in trial NCT05775718?
The interventions under investigation include: Zoster Vaccine Recombinant (DRUG).
Who is sponsoring clinical trial NCT05775718?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05775718 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers
RECRUITING · NA
-
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
RECRUITING · NA
-
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
RECRUITING · NA
-
BMT4me: Post-HSCT Medication Adherence mHealth App
RECRUITING · NA
-
Mosaic Trial for Stem Cell Transplant Recipients
RECRUITING · NA
-
Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.